Cephas Mujuruki, MD
Sleep Medicine · Wichita Falls, TXNPI 1376778951
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,078 of the $6,102 with a category attached, or 66.8%. 25 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 47.0% of the total. 2025 is the largest year on record at $2,139, 4.1 times the $526 reported in 2019.
Across 159 payments — averaging $38.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Jazz Pharmaceuticals Inc.$799
- Avadel CNS Pharmaceuticals, LLC$663
- Novo Nordisk$434
- Itamar Medical Inc$202
- Harmony Biosciences LLC$179
- plus $960 from 19 others
What the payments were for
- Consulting fees$2003%
- Travel & lodging$1,41023%
- Food & beverage$4,07867%
- Education$4147%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 23 | $2,865 |
| Jazz Pharmaceuticals Inc. | 20 | $799 |
| Avadel CNS Pharmaceuticals, LLC | 17 | $663 |
| Novo Nordisk | 32 | $434 |
| Itamar Medical Inc | 2 | $202 |
| Harmony Biosciences LLC | 5 | $179 |
| AstraZeneca | 9 | $135 |
| Pfizer | 8 | $127 |
| Bayer | 7 | $110 |
| GSK | 6 | $106 |
| Sanofi-aventis U.S. LLC | 6 | $85 |
| Philips North America LLC | 3 | $68 |
| Amarin Pharma, Inc. | 3 | $50 |
| Lilly USA, LLC | 4 | $50 |
| Johnson & Johnson | 2 | $32 |
| Genentech USA, Inc. | 2 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Nalpropion Pharmaceuticals LLC | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Fisher & Paykel Healthcare Inc | 1 | $20 |
| AbbVie | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Abbott | 1 | $16 |
| Merck | 1 | $11 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,425
- XYWAV$259
- LUMRYZ$200
- WatchPATONE$118
How this compares
$6,102 in reported general payments places this provider in the 80th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 14 | $9,600 |
| Lagevrio (Eua)Molnupiravir | 11 | $9,590 |
| PaxlovidNirmatrelvir/Ritonavir | 12 | $2,859 |
| Ramelteon | 16 | $1,880 |
| Eszopiclone | 27 | $942 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 79 | $696 |
| Gabapentin | 46 | $414 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $352 |
| Cefdinir | 22 | $337 |
| Zolpidem Tartrate | 40 | $303 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 24 | $258 |
| Trazodone Hcl | 44 | $232 |
| Fluticasone Propionate | 19 | $185 |
| Doxycycline Hyclate | 16 | $131 |
| Azithromycin | 25 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra, Lagevrio (Eua) | $11 | $19,19025 claims |
| PfizerPaxlovid | $127 | $2,85912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 112 sleep medicine providers in Texas.
Other sleep medicine in Wichita Falls
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.